Peptide arrays for kinome analysis: New opportunities and remaining challenges

Proteomics

Volumn 11, Issue 24, 2011, Pages 4595-4609

  Arsenault, Ryan ^a,b   Griebel, Philip ^a,b   Napper, Scott ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Kinase; Kinome; Peptide array; Phosphoproteome; Phosphorylation; Protein arrays

Indexed keywords

ADENOSINE TRIPHOSPHATE; KINOME; PHOSPHOPROTEOME; PHOSPHOTRANSFERASE; PROTEOME; UNCLASSIFIED DRUG;

ARABIDOPSIS; CANCER DIAGNOSIS; COST EFFECTIVENESS ANALYSIS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; KINOME ANALYSIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SPECIES COMPARISON; THREE DIMENSIONAL IMAGING;

ANIMALS; HUMANS; NEOPLASMS; PEPTIDES; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 82955187031     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100296     Document Type: Review

References (58)

1. Krebs, E. G., Fischer, E. H., Phosphorylase activity of skeletal muscle extracts. J. Biol. Chem. 1955, 216, 113-120.
2. Fischer, E. H., Krebs, E. G., Conversion of phosphorylase b to phosphorylase a in muscle extracts. J. Biol. Chem. 1955, 216, 121-132.
3. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., Sudarsanam, S., The protein kinase compliment of the human genome. Science 2002, 298, 1912-1934.
4. Hunter, T., Protein kinases and phosphatases: the yin and yang of protein phsophorylation and signaling. Cell 1995, 80, 225-236.
5. Manning, G., Caenepeel, S., Encyclopedia of protein kinases in human diseases, Catalog Reference Manual, Cell Signaling Technology, Beverly, MA, 2005.
6. Knuutila, S., Bjorkqvist, A. M., Autio, K., Tarkkaqnen, M. et al., DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol. 1998, 152, 1107-1123.
7. Cohen, P., Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 2002, 1, 309-315.
8. Hopkins, A. L., Groom, C. R., The druggable genome. Nat. Rev. Drug Discov. 2002, 1, 727-730.
9. Druker, B., Tamura, S., Buchdunger, E., Ohno, S. et al., Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 1996, 2, 561-566.
10. Druker, B., Talpaz, M., Resta, D., Peng, B. et al., Efficacy and safety of a specific inhibitor of the CR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 2001, 2, 561-566.
11. Noble, M., Endicott, J., Johnson, L., Protein kinase inhibitors: insights into drug design from structure. Science 2004, 303, 1800-1805.
12. Eglen, R. M., Reisine, T., The current status of drug discovery against the human kinome. Assay Drug Dev. Tech. 2009, 7, 22-43.
13. Liu, J., Farmer, J. D., Lane, W. S., Friedman, J. et al., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 199, 166, 807-815.
14. Heitman, J., Movva, N. R., Hall, M. N., Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253, 905-909.
15. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F. et al., A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372, 739-746.
16. Jalal, S., Kindrachuk, J., Napper, S., Phosphoproteome and kinome analysis: unique perspectives on the same problem. Curr. Anal. Chem. 2007, 3, 1-15.
17. Mann, M., Ong, S. E., Gronborg, M., Stern, H. et al., Trends Biotechnol. 2002, 20, 261.
18. Kalume, D. E., Molina, H. and Pandey, A., Tackling the phosphoproteome: tools and strategies. Curr. Opin. Chem. Biol. 2004, 7, 64-69.
19. Gorg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
20. Kreegipuu, A., Blom, N., Brunak, S., Jarv, J., Statistical analysis of protein kinase specificity determinants. FEBS Lett. 1998, 430, 45-50.
21. Zhu, H., Klemic, J. F., Chang, S., Bertone, P. et al., Analysis of yeast protein kinases using protein chips. Nature Genet. 2000, 26, 283-289.
22. Ouyang, Z., Takats, Z., Blake, T. A., Gologan, B. et al., Preparing protein microarrays by soft-landing of mass-selected ions. Science 2003, 301, 1351-1354.
23. Houseman, B. T., Huh, J. H., Kron, S. J., Mrksich, M., Peptide chips for the quantitative evaluation of protein kinase activity. Nature Biotech. 2002, 20, 270-274.
24. Kindrachuk, L., Potter, J., Wilson, H., Griebel, P., Napper, S., Activation and regulation of toll-like receptor 9: CpGs and beyond. Mini. Rev. Med. Chem. 2008, 8, 590-600.
25. Arsenault, R. J., Jalal, S., Babiuk, L. A., Potter, A. et al., Kinome analysis of toll-like receptor signaling in bovine monocytes. J. Recept. Signal. Transduct. Res. 2009, 29, 299-311.
26. Diks, S. H., Kok, K., O'Toole, T., Hommes, D. W. et al., Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 2004, 279, 49206-49213.
27. Turner-Brannen, E., Choi, K. G., Arsenault, R., El-Gagalwy, H. et al., Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1. J. Immunol. 2011, 186, 7127-7135.
28. Booth, J. S., Arsenault, R., Napper, S., Griebel, P. J. et al., TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides. J. Innate Immun. 2010, 5, 483-494.
29. Knight, Z. A., Lin, H., Shokat, K. M., Targeting the cancer kinome through polypharmacology. Nat. Rev. Cancer. 2010, 10, 130-137.
30. Sikkema, A. H., Diks, S. H., den Dunnen, W. F. A., ter Elst, A. et al., Kinome profiling in pediatric brain tumors as a new approach for target discovery. Cancer Res. 2009, 69, 5987-5995.
31. ter Elst, A., Diks, S. H., Kampen, K. R., Hoogerbrugge, P. M. et al., Identification of new possible targets for leukemia treatment by kinase activity profiling. Leukemia Lymphoma 2011, 52, 122-130.
32. Schrage, Y. M., Briaire-de Bruijn, I. H., de Miranda, N. F. C. C., van Oosterwijk, J. et al., Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment. Cancer Res. 2009, 69, 6216-6222.
33. Tuynman, J. B., Vermeulen, L., Boon, E. M., Kemper, K. et al., Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res. 2008, 68(4), 1213-1220.
34. Van den Broke, A., Arsenault, R., Cleuter, Y., Dehouck, C., Kinome profiling of bovine leukemia virus-indiced ovine leukemia: an approach for identifying altered signaling pathways and drugable targets in cancer. JAIDS 2011, 56, 98.
35. Ritsema, T., Joore, J., van Workum, W., Pieterse, C. J.M., Kinome profiling of Arabidopsis using arrays of kinase consensus substrates. Plant Methods 2007, 3, 3.
36. Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T., Manning, G., The mouse kinome: discovery and comparative genetics of all mouse protein kinases. Proc. Natl. Acad. Sci. USA 2004, 32, 11707-11712.
37. Gerdts, V., van den Hurk, S., Griebel, P., Babiuk, L., Use of animal models in the development of human vaccines. Future Med. 2007, 2, 667-675.
38. Wilkie, B. N., Mallard, B. A., Genetic effects on vaccination. Adv. Vet. Med. 1999, 41, 39-51.
39. Wilson, K. T., Crabtree, J. E., Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007, 133, 288-308.
40. He, S., Yang, Z., Skogerbo, G., Ren, F. et al., The properties and functions of virus encoded microRNA, siRNA, and other small noncoding RNAs. CRC Crit. Rev. Microbiol. 2008, 34, 175-188.
41. Hilhorst, R., Houkes, L., van den Berg, A., Ruijtenbeek, R., Peptide microarrays for detailed, high-throughput substrate identification, kinetic characterization, and inhibition studies on protein kinase A. Anal. Biochem. 2009, 387, 150-161.
42. Koppen, A., Houtman, R., Pijnenburg, D., Jeninga, E. H. et al., Nuclear receptor coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor y cofactor. Mol. Cell. Proteomics 2009, 8, 2212-2226.
43. Poot, A. J., van Ameijde, J., Slijper, M., van den Berg, A. et al., Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays. ChemBioChem 2009, 10, 2042-2051.
44. Sylvester, J. E., Kron, S. J., A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells. Mol. Cancer Ther. 2010, 9, 1469-1481.
45. Wu, D., Sylvester, J. E., Parker, L. L., Zhou, G., Kron, S. J., Peptide reporters of kinase activity in whole cell lysates. Biopolymers 2010, 94, 475-486.
46. Zetterqvist, O., Ragnarsson, U., Humble, E., Berglund, L., Engstrom, L., The minimum substrate of cyclic AMP-stimulated protein kinase, as studied by synthetic peptides representing the phosphorylatable site of pyruvate kinase (type L) of rat liver. Biochem. Biophys. Res. Commun. 1976, 70, 696-703.
47. Kemp, B. E., Graves, D. J., Benjamini, E., Krebs, E. G., Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J. Biol. Chem. 1977, 252, 4888-4894.
48. Parikh, K., Peppelenbosch, M. P., Kinome profiling of clinical cancer specimens. Cancer Res. 2010, 70, 2575.
49. Benovic, J. L., Strasser, R. H., Caron, M. G., Lefkowitz, R. J., Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. USA 1986, 83, 2797-2801.
50. Strasser, R. H., Benovic, J. L., Caron, M. G., Lefkowitz, R. J., Beta-agonist and prostaglandin EI-induced translocation of the beta-adrenergic receptor kinase: evidence that the kinase may act on multiple adenylate cyclase-coupled receptors. Proc. Natl. Acad. Sci. USA 1986, 83, 6362-6366.
51. Benovic, J. L., Mayor, F., Somers, R. L., Caron, M. G., Leftowitz, R. J., Light-dependent phosphorylation of rhodopsin by beta-adrenergic receptor kinase. Nature 1986, 321, 869-872.
52. Pouyssegur, J., Lenormand, P., Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur. J. Biochem. 2003, 270, 3291-3299.
53. Perillan, P. R., Chen, M., Potts, E. A., Simard, J. M., Transforming growth factor beta1 regulates Kir2.3 inward rectifier K+channels via phospholipase C and protein kinase C gamma in reactive astrocytes from adult rat brain. J. Biol. Chem. 2001, 227, 1974-1980.
54. Majumder, P. K., Mishra, N. C., Sun, X., Bharti, A. et al., Targeting of protein kinase C gamma to mitochondria in the oxidative stress response. Cell Growth Differ. 2001, 12, 465-470.
55. O'Flaherty, J. T., Chadwell, B. A., Kearns, M. W., Sergeant, S., Daniel, L. W., Protein kinases C translocation responses to low concentrations of arachidonic acid. J. Biol. Chem. 2001, 276, 24743-24750.
56. Skalhegg, B. S., Tasken, K., Specificity in the cAMP/PKA signalling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci. 2000, 5, d679-d693.
57. Alber, T., Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr protein kinases. Curr. Opin. Struct. Biol. 2009, 6, 650-657.
58. Schreiber, M., Res, I., Matter, A., Protein kinases as antibacterial targets. Curr. Opin. Cell Biol. 2009, 2, 325-330.